16-HEM-09-IN (INCB18424-271) A Single-Cohort, Phase 2 Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

  • Hildebrandt, Gerhard (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/22/1712/3/18